EBON vs CME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Mar 23, 2026

EBON

63.5
AI Score
VS
EBON Wins

CME

60.8
AI Score

Investment Advisor Scores

EBON

64score
Recommendation
BUY

CME

61score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric EBON CME Winner
Forward P/E 0 26.1097 Tie
PEG Ratio 0 5.8703 Tie
Revenue Growth 69.5% 8.0% EBON
Earnings Growth 0.0% 35.0% CME
Tradestie Score 63.5/100 60.8/100 EBON
Profit Margin -252.7% 62.6% CME
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Frequently Asked Questions

Based on our detailed analysis, EBON is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.